Health Technology Assessments
This article was originally published in SRA
Dr Peter Charlish looks at the role of technology assessment in the adoption of novel treatments.
You may also be interested in...
The path of spin-offs from loss-making biotech companies with weak investment propositions seems clouded with examples that often resulted in an appointment with the liquidator.
Executive orders signed by Joe Biden in the first days of his presidency to support the US pandemic response – including calling for a plan to bolster domestic manufacturing capabilities – have received a warm welcome from the AAM.
Viartris hopes its Viagra Connect two-pack will encourage British men to seek treatment for erectile dysfunction.